IPAM
ICICI Prudential Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Sell |
1,330
-48
| -3% | -$25.2K | 0.09% | 119 |
|
|
2025
Q1 | $874K | Sell |
1,378
-29
| -2% | -$18.4K | 0.11% | 108 |
|
|
2024
Q4 | $1M | Sell |
1,407
-8
| -0.6% | -$5.7K | 0.11% | 108 |
|
|
2024
Q3 | $1.49M | Buy |
1,415
+225
| +19% | +$237K | 0.16% | 93 |
|
|
2024
Q2 | $1.25M | Buy |
1,190
+116
| +11% | +$122K | 0.15% | 94 |
|
|
2024
Q1 | $1.03M | Buy |
1,074
+35
| +3% | +$33.7K | 0.12% | 99 |
|
|
2023
Q4 | $913K | Buy |
1,039
+90
| +9% | +$79K | 0.11% | 96 |
|
|
2023
Q3 | $781K | Buy |
949
+216
| +29% | +$178K | 0.1% | 93 |
|
|
2023
Q2 | $527K | Buy |
733
+45
| +7% | +$32.3K | 0.07% | 100 |
|
|
2023
Q1 | $565K | Buy |
688
+151
| +28% | +$124K | 0.08% | 91 |
|
|
2022
Q4 | $387K | Buy |
537
+144
| +37% | +$104K | 0.06% | 88 |
|
|
2022
Q3 | $271K | Buy |
393
+71
| +22% | +$49K | 0.04% | 93 |
|
|
2022
Q2 | $192K | Buy |
322
+16
| +5% | +$9.54K | 0.04% | 96 |
|
|
2022
Q1 | $212K | Buy |
306
+46
| +18% | +$31.9K | 0.03% | 94 |
|
|
2021
Q4 | $164K | Buy |
+260
| New | +$164K | 0.02% | 90 |
|